Circuit Split Doesn't Slow DOJ False Claims Act Settlements Based on FDCA Allegations

Bloomberg Law

Maya P. Florence

Partners Jennifer Bragg and Maya Florence and associate Neepa Mehta look at a circuit split regarding whether alleged violations of the Federal Food, Drug, and Cosmetic Act can, or should, give rise to violations of the False Claims Act. Jennifer, Maya and Neepa analyze the split and discuss its significance for pharmaceutical, biotech and medical device companies.